Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 06'th Dec 2024
BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeuti
Presidio Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
04:15pm, Friday, 06'th Dec 2024
SAN DIEGO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment
Dynamix Corporation Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing December 9, 2024
04:10pm, Friday, 06'th Dec 2024
Houston, TX, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Dynamix Corporation (the “Company”) today announced that commencing December 9, 2024, holders of the units sold in the Company's initial public offer
BloomZ Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
04:05pm, Friday, 06'th Dec 2024
TOKYO, JAPAN / ACCESSWIRE / December 6, 2024 / BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a Cayman Islands holding company with an operating subsidiary, Kabushiki Kaisha BloomZ, in Japan,
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 06'th Dec 2024
REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on December 4, 2024, the Compensation Committee of Adverum's Board of Director
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 06'th Dec 2024
WALTHAM Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved t
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 06'th Dec 2024
NAARDEN, The Netherlands and MIAMI, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutic
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Friday, 06'th Dec 2024
WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
F/m Investments Announces Listing Exchange Change for US Credit Series ETFs to Nasdaq
02:06pm, Friday, 06'th Dec 2024
WASHINGTON--(BUSINESS WIRE)--F/m Investments (“F/m”), a $16 billion multi-boutique investment firm and innovative provider of exchange-traded funds (ETFs), today announced that effective December
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 06'th Dec 2024
DALLAS, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-b
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 06'th Dec 2024
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, tod
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06:00am, Friday, 06'th Dec 2024
SOUTH SAN FRANCISCO, Calif. , Dec. 6, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therape
Jeffs' Brands Regains Compliance with Nasdaq Minimum Bid Price Rule
05:36am, Friday, 06'th Dec 2024
Tel Aviv, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketp
Nasdaq CFO Sarah Youngwood to Present at the Goldman Sachs U.S. Financial Services Conference
04:05pm, Thursday, 05'th Dec 2024
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.
Final Trades: Nasdaq, the IBIT and the IAU
01:20pm, Thursday, 05'th Dec 2024
The Investment Committee give you their top stocks to watch for the second half.
